Clinical trials are the foundation for determining best practice in MS care and for every new treatment option available in multiple sclerosis (MS) today, and they cannot happen without the involvement of people living with MS. In this webinar, Dr. Leorah Freeman, MS specialist and researcher, will break down the history and importance of clinical trials, explain how they work, and discuss why patient participation is vital to advancing MS care. Whether you are considering joining a trial, curious about how they shape treatment options, or simply want to better understand the process, this conversation will provide clear, accessible insights into the world of clinical research and its impact on the MS community.

About the Presenter

Leorah Freeman, MD, PhD, MSIN Principal Investigator is a neurologist specializing in multiple sclerosis and other neuroinflammatory conditions. She is the medical director of the MS and Neuroimmunology Center at UT Health Austin, and the clinical practice of Dell Medical School. Dr. Freeman serves as site principal investigator for the PCORI-funded DELIVER-MS study comparing the effectiveness of early intensive versus escalation approaches for treating relapsing-remitting multiple sclerosis. Dr. Freeman is the founder of the Texas MS Consortium, a network of clinicians, researchers, advocacy groups, and people with MS aiming to eliminate disparities in MS care and is also a member of MSAA’s Healthcare Advisory Council.